Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Anacor Pharmaceuticals Inc    

ANACOR PHARMACEUTICALS INC
Mes dernières consult.
Most popular
Report
 SummaryNewsCalendarCompanyFinancials 
Company
Anacor Pharmaceuticals, Inc. develops medical solutions.The firm operates as a biopharmaceutical company, which focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform.The company was founded by Lucy Shapiro, Stephen J.... 
Sector
Biotechnology & Medical Research
Calendar

- No events available -

More about the company
Latest news on ANACOR PHARMACEUTICALS INC
2016DJJazz Pharmaceuticals Agrees to Buy Celator for About $1.5 Billion
2016DJJazz Pharmaceuticals Nears Deal to Buy Celator for About $1.5 Billion
2016 Anacor received rival bid before Pfizer deal - filing
2016 Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Ana..
2016 Levi & Korsinsky, LLP Announces Investigation Into Whether the Sale of Anacor..
2016 ANACOR SHAREHOLDER NOTICE : Faruqi & Faruqi, LLP Announces the Investigation of ..
2016 Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Ana..
2016 Levi & Korsinsky, LLP Announces Investigation Regarding the Fairness of the S..
2016 ANACOR PHARMACEUTICALS SHAREHOLDER A : Former SEC Attorney Willie Briscoe and Po..
2016 RYAN & MANISKAS, LLP : Announces Investigation of Anacor Pharmaceuticals, Inc.
More news
Sector news : Biotechnology & Medical Research - NEC
10/18DJGILEAD SCIENCES : Cell-Therapy Drug Yescarta Gets FDA Approval -- Update
10/18DJGILEAD SCIENCES : Cell-Therapy Drug Yescarta Gets FDA Approval
10/18DJACTELION : J&J Net Income Falls After Actelion Deal -- WSJ
10/17 Regeneron-Sanofi drug succeeds mid-stage study
10/17DJJOHNSON & JOHNSON : Outlook Buoyed by Drug Unit -- Update
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
01/24 We're Hesitant On AnaptysBio's IPO
01/18 MERGERS AND ACQUISITIONS IN 2016 : Pause For Breath In A Shifting Market
2016 New Oral Psoriasis Drug Tops Cellceutix Catalysts
2016 BIOTECH FORUM DAILY DIGEST : A Volatile Few Days, Some Small Caps Blow Up, Spotl..
2016 Novan's IPO - Buying A Dollar For Twenty Cents
Income Statement Evolution
Managers
NameTitle
Douglas E. Giordano President, Chief Executive Officer & Director
Graeme Bell Chief Financial Officer & Executive Vice President
Jacob J. Plattner Senior Vice President-Research
Margaret M. Madden Director & Vice President
Bryan Supran Director
Sector and Competitors
1st jan.Capitalization (M$)
ANACOR PHARMACEUTICALS INC0
INCYTE CORPORATION13.96%24 054
QUINTILES IMS HOLDINGS INC33.89%22 162
LONZA GROUP59.15%19 392
CELLTRION, INC.--.--%19 297
ALNYLAM PHARMACEUTICALS, INC.208.84%10 522